Skip to main content

Table 1 Data of the patients who underwent bronchoscopic IIT

From: Bronchoscopic intratumoral injection of tranexamic acid to prevent excessive bleeding during multiple forceps biopsies of lesions with a high risk of bleeding: a prospective case series

Case #, gender, age(years) Location of lesion AO (approx. %) TEA nd/dd (mg) EBB (n) Histology
    Necrotic tumor (n = 8)
1 M(73) RMB 80 250/120 10 SqCC
2 M(41) RMB 90 250/120 5 SqCC
3 M(66) RB3 100 250/120 3 SqCC
4 M(64) RLLB 100 500/370 6 SqCC
5 M(72) RBB 100 500/370 3 SqCC
6 M(58) RULB 100 500/370 6 SqCC
7 M(64) RULB 90 500/370 5 AC
8 M(80)* LMB 100 500/370 5 MMT
     Hypervascular tumor (n = 12)
9 M(79) RBI 70 250/120 4 SqCC
10 M(58)* RMLB 90 250/120 3 SCLC
11 M(53) LULB 100 500/370 4 SqCC
12 M(61) LB4 80 500/370 5 SCLC
13 M(47) RMB 90 500/370 6 SqCC
14 M(50) LULB 50 500/370 7 AC
15 M(62) RMB 90 500/370 9 SqCC
16 M(60) Trachea-LMB 50-80 500/370 6 SqCC
17 M(59) LULB 80 500/370 6 SCLC
18 M(64) RULB 100 500/370 6 SqCC
19 M(53) LULB 50 500/370 7 SqCC
20 M(67) RBI 60 500/370 7 SqCC
  1. *Continuous dual antiplatelet therapy (aspirin and clopidogrel).
  2. AC- adenocarcinoma; AO-airway obstruction; dd-approximate delivered dose; EBB-endobronchial forceps biopsy; LB4- superior lingular segmental bronchus; LMB- left main bronchus; LULB- left upper lobe bronchus; MMT- malignant mesenchymal tumor; nd-nominal dose; RBB-right basal bronchus; RBI- Right bronchus intermedius; RB3- right upper lobe anterior segmental bronchus; RLLB -right lower lobe bronchus; RMB - right main bronchus; RMLB-right middle lobe bronchus; RULB-right upper lobe bronchus; SCLC- small-cell lung carcinoma; SqCC- squamous cell carcinoma; TEA-tranexamic acid.